Dr Michelle Kam Li Wei

Dr Michelle Kam is a Senior Consultant respiratory medicine specialist at O2 Lung Centre. She practices at Gleneagles Hospital, Mount Alvernia Hospital, Mount Elizabeth Novena Hospital and Mount Elizabeth Orchard Hospital. She is also a visiting consultant at Singapore General Hospital (SGH) and currently serves as the Asian Pacific Society of Respirology (APSR) ILD Assembly Deputy Head.

Dr Kam is a graduate from the Yong Loo Lin School of Medicine (National University of Singapore) where she was awarded the Class of 1975 Book Prize. She completed the Singhealth Internal Medicine  Residency Program and Singhealth Respiratory Medicine Senior Residency Program. During her training, she obtained her Master of Medicine (Internal Medicine) and became a Member of the Royal College of Surgeons (Edinburgh), and Member of the Royal College of Physicians (United Kingdom). She also received the Singhealth Best House Officer Award.

In addition to practicing general respiratory medicine and treating conditions including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and chronic cough, Dr Kam also performs procedures including bronchoscopy and endobronchial ultrasound (EBUS). Her clinical interests are in ILD and rare lung diseases. She completed a subspecialty fellowship in ILD, at National Jewish Health, a leading respiratory center in the USA, with one of the largest and most established ILD programs in the nation. During her fellowship, she also received training in sarcoidosis and granulomatous lung disease, orphan and cystic lung disease (e.g. lymphangioleiomyomatosis (LAM), Birt-Hogg Dube Syndrome, pulmonary Langerhans cell histiocytosis), childhood ILD and pulmonary genetics.

Prior to commencing private practice, she served as a consultant respiratory physician at SGH where she was part of the ILD service, which included multidisciplinary clinics with rheumatologists, and was part of a multidisciplinary workgroup for immunotherapy-related toxicities. Dr Kam was associate director of the hereditary hemorrhagic telangiectasia (HHT) treatment centre at SGH and established a dedicated multi-disciplinary HHT clinic which is recognized as a centre of excellence by the Cure HHT Foundation. She also established a dedicated cystic lung disease clinic, providing patients with comprehensive diagnosis, and multisystemic screening and surveillance in one setting. Dr Kam received the Service with a Heart Award during her time at SGH.

Her research interests include high-risk ILD subtypes with a focus on genetic and molecular risk profiling, and her work has been published in international peer-reviewed journals and presented at international conferences. She has been an invited speaker, faculty member, and chairman at local, regional and international conferences and symposiums. Dr Kam has been awarded several research grants as principal investigator and received the inaugural Singapore Thoracic Society Young Investigator’s Award in 2022, as well as the 2025 ATS-APSR Travel Award.

Dr Kam was actively involved in both undergraduate and postgraduate medical education. Prior to private practice, she held positions as physician faculty for both the Singhealth Internal Medicine Residency Program and Respiratory Medicine Senior Residency Program, and was a Clinical Assistant Professor with Duke-NUS Medical School, Clinical Lecturer with the NUS Yong Loo Lin School of Medicine, and Clinical Teacher with the Lee Kong Chian School of Medicine.